NCT04945031 is a clinical trial of cannabis in Cannabis, sponsored by Mahidol University.

Who is sponsoring NCT04945031?

NCT04945031 is sponsored by Mahidol University.

What drugs are being tested in NCT04945031?

Interventions in NCT04945031: cannabis.

Is NCT04945031 still recruiting?

NCT04945031 is currently completed. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04945031

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Study of Pharmacological Treatment Pattern for Cannabis-induced Psychosis

Completed Last updated 30 June 2021

What this trial tests

trial testing cannabis in Cannabis in 317 participants. Completed in 31 December 2020.

Timeline

8 November 2019

Primary endpoint
31 May 2020

31 December 2020

Quick facts

Lead sponsor	Mahidol University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	317
Start date	8 November 2019
Primary completion	31 May 2020
Estimated completion	31 December 2020
Sites	1 location across Thailand

Drugs / interventions tested

cannabis — full drug profile →

Conditions studied

Cannabis — all drugs for Cannabis →

Sponsor

Mahidol University

Who can join

12 and older, any sex, with Cannabis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional and retrospective chart review study was conducted at the Princess Mother National Institute on Drug Abuse Treatment (PMNIDAT), Thailand. All patients who admitted at PMNIDAT from October 2013 to September 2019 were included. Patients aged 18-65 years who met the International Classification of Disease-10 (ICD-10) criteria of CIP and Had a positive urine test of cannabis were included. Cannabis use is a component cause of psychosis.More than half of symptoms of cannabis-induced psychosis (CIP) were hallucination, delusion, irritable and anxiety. Antipsychotic drug was still a key psychotropic drugs for treatment of CIP. However, antidepressants and benzodiazepines were commonly used for treatment of other symptoms beyond psychotics

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study.
Chuenchom O, Suansanae T, Lukanapichonchut L, Suwanmajo S, et al · · 2024 · cited 2× · PMID 39334053 · DOI 10.1186/s12888-024-06075-6

Verify or expand the search:

Other trials of cannabis

Trials testing the same drug.

NCT03122691 — Differences in Cannabis Impairment and Its Measurement Due to Route of Administration · Phase 1 · completed
NCT02817698 — Imaging the Neurochemistry of Drug Addiction With PET · EARLY_PHASE1 · completed

Other recruiting trials for Cannabis

Currently open trials in the same condition.

NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
NCT07417059 — Sex Hormones Impact on Cannabis Response · NA · recruiting
NCT07194018 — Use of Cannabis Oil in Fibromyalgia · active not recruiting
NCT06099379 — Modulation of THC Effects by CBD: a Dose-ranging Study · Phase 1, PHASE2 · recruiting
NCT05742724 — The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol · Phase 1 · active not recruiting

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04945031 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing